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ABSTRACT Insights into the interacting mode of CXCR4 with SDF-1a are crucial in understanding the structural and
functional characteristics of CXCR4 receptor. In this paper a computational pipeline, integrating protein structure prediction,
molecular dynamics simulations, automated molecular docking, and Brownian dynamics simulations were employed to
investigate the dynamic and energetic aspects of CXCR4 associating with SDF-1a. The entire simulation revealed the surface
distribution feature of electrostatic potentials and conformational ‘‘open-close’’ process of the receptor. The possible binding
conformation of CXCR4 was identiﬁed, and the CXCR4—SDF-1a binding complex was generated. Arg188-Glu277 salt bridge
plays an important role for both the extracellular domain conformational change and SDF-1a binding. Two binding sites were
mapped at the extracellular domain (Site 1) and inside the transmembrane domain (Site 2), which are composed of conserved
residues. Sites 1 and 2 contribute ;60% and 40% to the binding afﬁnity with SDF-1a, respectively. The binding model is in
agreement with most of the experimental data. Transmembrane VI has more signiﬁcant motion in the harmonious
conformational transition of CXCR4 during SDF-1a binding, which may be possibly associated with signal transduction. Based
on the modeling and simulation, a binding mechanism hypothesis between CXCR4 and SDF-1a and its relationship to the
signal transduction has been proposed.
INTRODUCTION
Chemokines are the largest superfamily of cytokines that
regulate the recruitment of various types of leukocytes sites
associated with inﬂammation and many other immune
responses (Zlotnik and Yoshie, 2000; Mackay, 2001; Moser
and Loetscher, 2001). Stromal cell-derived factor-1a (SDF-
1a) is a CXC chemokine with chemoattractant activity for
lymphocytes, monocytes, and their progenitor cells (Gerard
and Rollins, 2001). It is the only known endogenous ligand
for the CXC chemokine receptor 4 (CXCR4) (Schwarz and
Wells, 1999). The crystal structure of a variant SDF-1a
([N33A]SDF-1a; see Dealwis et al., 1998; PDB code of 1A15
at 2.2 A˚ resolution) has shown that SDF-1a adopts a typical
chemokine b-b-b-a topology. The NMR studies (Crump et
al., 1997; Elisseeva et al., 2000) have demonstrated that SDF-
1a binds with the CXCR4 in the form of monomer and the
N-terminal eight residues form an important receptor binding
patch. Modiﬁcation of Lys1 and/or Pro2 (Crump et al., 1997)
results in loss of activity of CXCR4, but still generates potent
SDF-1a antagonist. It was also proposed (Crump et al., 1997;
Loetscher et al., 1998) that the RFFESH motif (residues
12–17) is another receptor binding site and launches the initial
docking of SDF-1a with its receptor.
CXCR4 belongs to the peptide receptor and rhodopsin-
class of G-protein–coupled receptor (GPCR) superfamily
(Loetscher et al., 1994). It has been identiﬁed as a coreceptor
for T-tropic HIV-1 and CD4-independent HIV-2 fusion and
infection (Zhao et al., 1999; Moore and Stevenson, 2000;
Chabot and Broder, 2000). The coreceptor activity can be
impaired by amino acid changes of the conserved elements
in CXCR4, especially the conserved residues at the Nter
(Brelot et al., 2000). More recent investigations provided
molecular support that SDF-1a and CXCR4 have a critical
role in determining the metastatic destination of breast
cancer cells (Liotta, 2001; Thelen, 2001). Neutralizing the
interaction of SDF-1a with CXCR4 can signiﬁcantly impair
metastasis of breast cancer cells to regional lymph nodes
and lung (Muller et al., 2001). Therefore, the SDF-1a and
its receptor CXCR4 might qualify as targets for ‘‘chemo-
prevention’’—the hope for new therapeutics of breast cancer
(Schwarz and Wells, 1999; Muller et al., 2001).
Although molecular and cell biological studies have
provided some essential insights into the functions of both
SDF-1a and CXCR4, the increasingly prominent roles of
SDF-1a and CXCR4 in the regulation of HIV-1 infection
and metastasis of breast cancer have also been revealed
(Gerard and Rollins, 2001; Muller et al., 2001; Babcock
et al., 2001; Cheng et al., 2000). These insights have in turn
raised new questions. For example, the structural elements of
CXCR4 that mediate the interaction with SDF-1a have not
been precisely deﬁned due to the difﬁculty for determining
its x-ray structure; in addition, the mode for SDF-1a binding
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with CXCR4 and the receptor activation has not been clearly
demonstrated at molecular level. Therefore, exploring
the conformational determinants of the extracellular do-
main of CXCR4, investigating the dynamic features of
CXCR4—SDF-1a binding process, and mapping the re-
ceptor activating mechanism become of great interest to us.
Structure-function relationship studies (Zhao et al., 1999;
Ling et al., 1999; Chabot and Broder, 2000; Cheng et al.,
2000; Bennett et al., 2001) demonstrated the importance
of CXCR4—SDF-1a in pharmaceutical research, further
motivating this theoretical study.
Computational simulation studies can aid in the inter-
pretation of mutagenesis, binding, and other experimental
data on GPCRs, and can provide new clues for identifying
covered functions of GPCRs and for designing new ligands.
Recently, great success has been achieved in the ﬁeld of
structure prediction of GPCRs (Perera et al., 2000; Orry and
Wallace, 2000). Combining with experimental information,
a lot of matured algorithms (Filizola et al., 1999; Jayasinghe
et al., 2001; Baker and Sali, 2001) are capable of predicting
the TM structures (Palczewski et al., 2000; Teller et al.,
2001). However, constructing appropriate conformational
spaces of extracellular or intracellular domains remains
a major challenge in the 3D structural modeling of GPCRs.
Long-time MD simulations (Duan and Kollman, 1998) take
the advantage of iteratively tracking the trajectory of con-
formational change, and therefore, may capture the ligand
binding (or bioactive) conformation of GPCRs. In this study,
a robust approach, integrating homology modeling, long-
time MD simulations, molecular docking, and Brownian
dynamics, has been employed in studying the association
process of SDF-1a with CXCR4. The simulation results
elucidated the following aspects about CXCR4—SDF-1a
interaction: what kind of conformation (bioactive conforma-
tion) CXCR4 adopts when it associates with SDF-1a; how
SDF-1a binds with CXCR4; and how SDF-1a induces the
signal transduction. In addition, these simulations are, to our
knowledge, the ﬁrst of long-time MD study that reveals the
bioactive conformation of CXCR4 associating with SDF-1a.
MATERIALS AND METHODS
Experimental studies (Dealwis et al., 1998; Crump et al., 1997; Elisseeva
et al., 2000; Loetscher et al., 1998; Zhao et al., 1999; Chabot and Broder,
2000) have indicated that SDF-1a binds with CXCR4 at two binding sites;
one lies on the ED and the Nter of CXCR4, and must have a pivotal role
in the binding site formation. As mentioned above, there are several methods
for modeling the structure of TMs. However, it is difﬁcult for constructing
the structure of ED. Furthermore it is more difﬁcult to identify the pos-
sible bioactive conformation for CXCR4 that SDF-1a binds with. To solve
these problems, we integrated several modeling and simulation methods in
this study. The computational pipeline is outlined in Scheme 1. Brieﬂy, the
computational ﬂow is as follows. 1) Segmented approach including ho-
mology modeling was used to construct the 3D structural model of CXCR4.
2) Long-timeMD simulations were carried out on the ﬂexible ED of CXCR4;
the lower-energy conformations in the MD trajectory were picked out for
following protein-protein docking simulations. 3) Protein-protein docking
was divided into two steps: ﬁrst, the probing ligand extracted from the Nter
of SDF-1a was docked to the possible binding site inside the TMs using
automated molecular docking method. Next, the BD simulations were
performed on the association of the rest part of SDF-1a with all the possible
low energy conformations of CXCR4, thus ﬁnding the possible binding
conﬁguration of SDF-1a—CXCR4 complex according to the binding
features and binding free energy. 4) Finally, the entire binding complex was
further reﬁned using the molecular mechanics method.
3D structural modeling of CXCR4
The modeling described here utilizes a segmented approach where the N
terminus, the transmembranes, and the extracellular loop regions were
separately modeled. The intracellular loops and the C terminus were not
modeled, as they are not directly involved in the binding of SDF-1a.
Modeling a-helix bundle
Sequence analysis and conserved-residues identiﬁcation were carried out
among chemokine receptors and other rhodopsin-like GPCRs, totally 49
sequences of CC and CXC types were from http://www.expasy.ch/prosite
and 115 sequences from http://www.gpcr.org/7tm. Using the crystal
structure of bovine rhodopsin (PDB code of 1F88 at 2.80 A˚ resolution,
Palczewski et al., 2000; Teller et al., 2001) as a template, the Homology
module of InsightII (version 2000, Accelrys, San Diego, CA) and the
ClustalW algorithm (Thompson et al., 1994) were applied in sequence
alignment, and the Blosum scoring matrix (Henikoff and Henikoff, 1992)
was employed to obtain the best-ﬁt alignment. The best alignment was
selected not only according to the value of the alignment score, but also the
reciprocal positions of conserved residues. The TMs domain was identiﬁed
and transformed into a-helices and the nonequivalent amino acids were
mutated to produce CXCR4 sequence.
Modeling extracellular loops and Nter
The FASTA program (Pearson, 1990) was used to identify sequence
homologs through the in-house database (Huang et al., 2000) containing 700
loops and proteins with medium to high sequence identity. ClustalW
(Thompson et al., 1994) was then used to determine the fragments that had
higher homology with the loops and the Nter of CXCR4. The reasonable
fragment conformation was chosen from the top 10 candidates that had the
lowest root mean square (RMS) values and considerable geometrical
compatibility. The conserved disulﬁde bond between residues Cys109 at the
beginning of TM III and Cys186 at the middle of extracellular loop 2 (EL-2)
was also created and kept as a constraint in the geometric optimization.
SCHEME 1
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Structure optimization
The receptor was optimized using the molecular mechanics method with
the following parameters: a distance-dependent dielectric constant of 5.0;
nonbonded cutoff 8 A˚ , Amber force ﬁeld (Cornell et al., 1995) and Kollman-
all-atom charges; and conjugate gradient minimization until the energy
gradient RMS,0.05 kcal (mol A˚ )1. The whole receptor was minimized to
convergence. At the end, the HBPLUS algorithm (McDonald and Thornton,
1994) was used to calculate the interhelical hydrogen bonds, and the
modeled structure was validated with PROCHECK (Laskowski et al., 1993)
and WHATIF (Vriend and Sander, 1993).
Molecular dynamics simulations
The MD simulation was run on a 64 CPU parallel computer using the
program EGO_VIII (Eichinger et al., 2000) including the CHARMM19
force ﬁeld (Brooks et al., 1983). The TIP3P water model (Jorgensen et al.,
1983; Neria et al., 1996) was used to simulate the solvent. The most
popular Verlet algorithm (Verlet, 1967) was adopted to integrate the equation
of motion and the FAMUSAMM algorithm (Eichinger et al., 1997) was
applied to rapidly evaluate electrostatic interactions, while the lengths of
bonds involving hydrogen atoms were held ﬁxed with the SHAKE algorithm
(Ryckaert et al., 1977).
The initial coordinates of the ED of CXCR4 were extracted from the
energy minimized structural model of CXCR4 receptor. The end of each
loop together with the end of the Nter connecting helix I was three residues
extended to the relative helices. The backbone of these three residues and the
peptide bond at the seven ends were kept in torsion angle constraints so that
the whole ED could connect to the TMs domain. The ionization states at
neutral pH for the acidic, basic residues, and histidines were determined
through pKa calculation by using the DelPhi module of molecular modeling
software, InsightII (release 2000, Accelrys). The solute was then solvated at
the center of a sphere of water molecules, which ensures the whole simu-
lation system to be covered by water molecules at least 10-A˚ thick. The seven
ends connecting the loops and Nter were ﬁxed by adding a stiff harmonic
potential so that the loops and Nter had enough moving space during
the whole simulation process. To provide a neutral simulation system,
the SOLVATE release 1.0 (http://www.mpibpc.gwdg.de.abteilungen/071/
solvate/node4.html) was applied to add the counterions in the bulk solution;
therefore, the sodium ions were placed in the solvent volume at physiological
concentration (0.154 M) obeying the Debye-Hu¨ckel distribution. Each
charged atom at the surface of the solute was surrounded by a ‘‘cloud’’ of so-
called counterions, and the size of this cloud was given by the Debye-Hu¨ckel
length. The total number of atoms in the simulation system was 26,932,
including 1424 atoms of the protein and 8500 water molecules.
After the initial structures were prepared, energy minimization was
performed at constant volume for all the water molecules with the criterion
of the maximum force of the whole system decreased below 10.00 kcal
(mol A˚ )1, to optimize poor steric contacts. And then, the whole system was
energy minimized with the same criterion. The friction factor t was set
as 0.1 at the end of each integration step during the minimization process,
and then changed to 1.0 for the MD equilibrium simulation. As the
minimization convergence was reached, the whole system was directly
subjected to a slow heating procedure for ;20 ps in a heat reservoir of
300 K. After that, the system was performed a 2.5-ns (2.5 3 109 s) MD
simulation. Because the FAMUSAMM algorithm (Eichinger et al., 1997)
was adopted, 1 fs (1 3 1015 s) was used as the time step, and the frequency
for analyzing the MD output was set as 1 ps (1 3 1012 s).
CXCR4—SDF-1a association simulation
Automated molecular docking
For the reason of tackling the interacting mode of SDF-1a with CXCR4, the
CAST program (http://cast.engr.uic.edu; see Liang et al., 1998) was used to
identify the possible voids and pockets situated in the TMs domain, where
were the potential sites for ligand binding (Site 2). Since the Nter of SDF-1a
is ﬂexible, the small molecule-protein docking method was used in
identifying the possible binding conformation of the Nter. Employing the
AutoDock3.0 program (Morris et al., 1998), different probing polypeptides
(the Lys-Pro, Lys-Pro-Val, and the Lys-Pro-Val-Ser), extracted from the
end of Nter of SDF-1a, were docked into the pocket candidates derived
from CAST calculations. The N terminus of these peptides was treated as
protonated state to simulate the actual environment of SDF-1a interacting
with CXCR4. During the docking process, conformational search was
performed using the Solis and Wets local search method (Solis and Wets,
1981), and the Lamarckian genetic algorithm was applied to deal with the
ligand-receptor interaction. A series of docking parameters were set on. Not
only the atom types but also the generations and the number of runs for
the LGA algorithm were edited and properly assigned according to the
requirement of the Amber force ﬁeld. The number of generation, energy
evaluation, and docking runs was set to 370,000, 1,500,000, and 10, re-
spectively. The interacting energies of the probing ligands with CXCR4
were assessed by the empirical binding free energy function including the
desolvation and the hydrophobic effect (Morris et al., 1998). Thus the score
function was sufﬁcient to rank the binding conformations of probing ligands
and their orientations associating with Site 2 of CXCR4.
Brownian dynamics simulations
After getting the appropriate binding conformation and orientationof theNter,
thebinding featureof the rest part ofSDF-1awithCXCR4canbe simulatedby
the BD method. The ﬂexibility of the ED of CXCR4 was considered by
respectively docking SDF-1a into all the possible energy-minima conforma-
tions of CXCR4 that were extracted from the above MD simulations. The
MacroDox program package (S.H. Northrup, Tennessee Technological
University, Cookeville, TN) was used to perform BD simulations.
The detail procedure of BD simulation has been described in several
papers (Northrup et al., Tennessee Technological University; Warwicker
and Watson, 1982; Smoluchowski, 1917; Ermak and McCammon, 1978;
Cui et al., 2001, 2002). Here we only brieﬂy introduce the BD simulation
process. The new updated charge ﬁle of CHARMM22 (Brooks et al., 1983)
was used to assign the charges for SDF-1a and CXCR4. The Tanford-
Kirkwood method of Matthew (1985; Matthew and Gurd, 1986) was
employed to determine the protonation status of each titratable residue of
two proteins at pH of 7.0 and ionic strength of 0.1 M. As the main purpose
of BD was to ﬁnd reasonable recognition conformation of SDF-1a with
CXCR4 on the scale of feasible computational facility, the TK recom-
mended partial charges were assigned to CXCR4 and formal charges were
assigned to SDF-1a, and the total charge was 9.86 e for ED-CXCR4 and
7.20 e for SDF-1a. Although this test charge model was not as efﬁcient as
that of the effective charge method, it has been demonstrated in our previous
work that the test charge model produced reasonable results for the
interaction of protein-protein binding (Cui et al., 2001, 2002; Fu et al.,
2002), therefore, it was applied again in the present study. After charge
assignment, the electrostatic potentials about CXCR4 and SDF-1a were
calculated by numerically solving the linearized Poisson-Boltzmann
equation using the method of Warwicker and Watson (Warwicker and
Watson, 1982). The protein interior dielectric constant and solvent dielectric
constant were set as 4.0 and 78.3, respectively.
The BD simulation of the two interacting macromolecules in solvent
was run stochastically by a series of small displacements chosen from
a distribution that is equivalent to the short time solution of the Smoluchowski
diffusion equation (Smoluchowski, 1917) derived from different forces. The
basic Ermak-McCammon algorithm (Ermak and McCammon, 1978) was
employed to simulate the translational and rotational Brownianmotion of two
interacting proteins. BD simulations of SDF-1a binding to CXCR4 were
performed to identify the possible favorable complex, typically by running
3000 trajectories. The mobile SDF-1a was subject to three forces:
electrostatic attraction between two proteins, random Brownian force, and
frictional force due to solvent viscosity. The closest approaches of SDF-1a
complexing with CXCR4 were recorded as trajectories.
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Binding model reﬁnement
Synthesizing the results of molecular docking and BD simulations, the
bioactive conformation of CXCR4 and the possible SDF-1a—CXCR4
binding model were obtained. During this process, the best binding model
was identiﬁed from a set of 10 candidates resulting from molecular docking
and BD simulations, and the geometrical complementary and the lowest-
energy principle were adopted as the criteria. The ﬁnal structure of the
complex was subjected to energy minimization using the same molecular
mechanics method just as that for structural optimization of the receptor. The
details of the interaction were analyzed using the LIGPLOT program
(Wallace et al., 1995).
RESULTS
Structural model of CXCR4 receptor
Structural features
The primary 3D model of CXCR4 (TMs þ ED) that resulted
from the structural modeling is shown in Fig. 1. The
PROCHECK (Laskowski et al., 1993) statistics showed that
90% of the residues in the CXCR4 model are in either the
most favored or in the additionally allowed regions of the
Ramachandran plot. The overall main chain and side chain
parameters, as evaluated by PROCHECK, are all very fav-
orable. The WHATIF (Vriend and Sander, 1993) validation
found loose RMS Z-scores, which are typical of modeled
structure. The topology of TMs arrangement is in accordance
with the helical conformation of GPCRs (Table 1).
Networks of intramolecular interactions
Two kinds of interacting networks are observed: aromatic
residue clusters and hydrogen bond (H-bond). In the ﬁrst
network, aromatic residues are observed to assemble three
clusters, maintaining the geometry of the TMs by the
favorable stacking interactions as in known membrane
proteins (Adamian and Liang, 2001; Ulmschneider and
Sansom, 2001). One aromatic cluster (Fig. 1, cluster 1)
locates at the upside of TMs I, II, and VII, being composed of
the conserved residues Tyr45, Phe49, Phe87, Trp94, Phe292,
and Phe293; these aromatic interactions make TMs I, II, and
VII congregate tightly. Another aromatic cluster (Fig. 1,
cluster 2) locates close to the lower part of TMs II, III, and
IV formed by the side chains of Tyr76, Tyr121, Phe129,
Tyr157, and Trp161. The hydrophobic environment formed
by these residues directly affects the conformational changes
of the functionally important motif DRY at the C-terminal of
TM III, especially the disruption and formation of the salt
bridge between Asp133 and Arg134. The third aromatic
cluster (Fig. 1, cluster 3), formed by residues Phe248,
Phe249, Trp252, Tyr255, and Tyr256, packs TM VI with
TMs V and VII through van-der-Waals interactions.
The second network is formed by hydrogen bonds
between residues conserved across the chemokine receptor
subtypes (Table 2). The presence of hydrogen bond
interaction with only TM VII could allow relative movement
of TM VI. The speciﬁc hydrogen bonds cluster formed
among residue Tyr302 and the DRY motif of TM III may be
one of the structural constraints keeping the receptor
inactive.
MD simulations
Structural dynamics
As indicated in Fig. 2, the total energy (potential energy plus
kinetic energy) of the system decreases rapidly to the average
value of 6.59 3 105 kcal/mol. After ;200 ps, the whole
FIGURE 1 Cartoon representation of 3D model for CXCR4 receptor.
Intramolecular hydrophobic interactions represented as three aromatic
clusters are also shown: 1) cluster among TMs I, II and VII; 2) cluster
among TMs II, III and IV; and 3) cluster among TMs VI and VII. (A) Side
view. (B) Top view from the intracellular side (without loops and Nter for
clear visual of TMs).
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system is becoming stable. Using the total energy ﬂuctuation
as the criteria for monitoring conformational changes, the
local energy-minima conformations were identiﬁed and the
corresponding points on the energy curve are also indicated
in Fig. 2 (dotted lines).
The time-evolution RMS deviation (RMSD) and relative
RMS ﬂuctuation (RMSF) of individual residues of the Nter
are graphically shown in Fig. 3. Due to its ﬂexible nature, the
conformation of the Nter changes rapidly and dramatically as
reﬂected in the RMSD curve (Fig. 3 A). Compared with the
great ﬂuctuations of several residues at the tail of Nter and
residues of Tyr7 and Met16, the ﬂuctuation scale of residues
9–14 is relatively small (Fig. 3 B). Conformational analysis
demonstrates that there are two conserved motifs in the
secondary structure of Nter. One motif (motif 1), formed by
Ile4 to Tyr12, has the secondary structure of b-sheets. The
superimposed conformations, taken from the snapshots with
an interval of 50 ps plus those at the energy-minima, are
graphically represented in Fig. 3 C. Residues Ile4 to Ile6 and
Ser9 to Tyr12 have formed paralleling b-sheets, and residues
Tyr7 to Thr8 are at the turn of the b-sheets. Another motif
(motif 2) is composed of Thr13 to Asp22, which contains
several negative-charged residues such as Glu14, Glu15, and
Asp20. As shown in Fig. 3 D, residues Thr13 to Glu15 and
Asp20 to Asp22 in motif 2 form a b-sheet–like secondary
structure. The whole structures of these two motifs are
conserved over a long time period as indicated by the curves
of RMSD changes in Fig. 3 A.
Extracellular loops have small scale of structural move-
ments except for EL-2. From the RMSF values in Fig. 3 B
we can see that EL-1 and EL-3 have little structural
perturbation on the whole ED-CXCR4. Conformational
ﬂuctuation of EL-3 comes from the ﬂexibility of itself and
FIGURE 2 Total energy changes of the solvated CXCR4 system as the
function of time. Dotted lines indicate the local energy-minima represen-
tative of typical conformations.
TABLE 2 Hydrogen bonds (beyond the backbone) formed by
residues of TMs
Donor Acceptor
Location Residue Group Group Residue Distance (A˚ )
TM4-TM2 Trp161 NeH Ne His79 3.28
TM2-TM4 Tyr76 OH O¼C, Glu153 3.52
TM2-TM4 Lys75 NeH OH Tyr157 2.68
TM4-TM2 Lys154 NeH OH Ser71 2.70
TM2-TM2 Met72 NH OH Ser71 3.00
TM4-TM4 Thr168 OH O¼C, Ala164 2.76
TM1-TM2 Asn56 NdH Od1 Asp84 2.70
TM1-TM2 Asn56 NdH O¼C, Leu80 2.74
TM2-TM2 Thr90 OH O¼C, Leu86 2.74
TM5-TM5 Gln202 NeH NeH His203 3.18
TM5-TM5 Ser217 OH O¼C, Ile213 2.74
TM5-TM5 Ser224 OH O¼C, Cys220 2.74
TM6-TM6 Thr240 OH O¼C, Ala237 2.71
TM7-TM6 Thr287 OH Od1 Asp262 2.66
TM1-TM7 Tyr45 OH Oe1 Glu288 2.60
TM7-TM3 Tyr302 OH Od1 Asp133 2.61
TM3-TM3 Arg134 Nh1H Od2 Asp133 2.59
TM3-TM3 Arg134 Nh2H Od2 Asp133 2.60
TM3-TM7 Arg134 Nh1H OH Tyr302 2.61
TM2-TM7 Arg77 NeH O¼C, Ala303 3.26
TM2-TM7 Arg77 Nh1H O¼C, Ala303 2.73
TM2-TM2 Arg77 Nh2H O¼C, Thr73 2.73
TM2-TM7 Thr73 OH O¼C, Gly306 2.84
TM2-TM2 Ser81 OH O¼C, Leu78 2.71
TM3-TM3 His113 NdH O¼C, His113 2.87
TM3-TM3 Ser122 OH O¼C, Asn119 2.71
TM3-TM3 Ser123 OH O¼C, Leu120 2.75
TM3-TM3 Ser131 OH O¼C, Ala128 2.73
TM7-TM7 His294 Ne O¼C, Leu290 2.78
TABLE 1 Structural data for TMs of CXCR4
TM TM center (x, y, z)/A˚ Tilt angle of TM (u)/degree Bends within TM (x)/degree
TM I 12.34, 6.02, 3.28 20.96 Almost straight
TM II 10.16, 2.15, 2.04 26.78 23.06 (Pro92)
TM III 1.76, 3.75, 0.75 27.89 Almost straight
TM IV 3.29, 13.12, 0.48 5.10 5.51 (Pro163); 13.48 (Pro170)
TM V 11.87, 1.75, 0.78 36.00 23.72 (Pro211)
TM VI 7.47, 8.39, 0.65 15.96 16.12 (Pro254)
TM VII 2.65, 7.10, 2.41 5.89 6.72 (Pro299)
TM packing angles
TM1-TM2 TM2-TM3 TM3-TM4 TM4-TM5 TM5-TM6 TM6-TM7 TM7-TM1
156.98 159.55 157.17 149.25 160.15 161.57 164.52
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the structural mediation by the Nter. Only several residues
in EL-1 and EL-3 have great contribution to the RMS
ﬂuctuations of the loops. These residues are Val99, Trp102,
and Phe104 from EL-1, and Ile269, Ile270, and Cys274 from
EL-3. Most residues of EL-1 have been involved in
hydrophobic interactions with the extracellular end of TMs
I and II. Residues 188–195 of EL-2 contribute the most part
to the conformational ﬂuctuations.
Electrostatic properties of ED-CXCR4
To explore surface properties, electrostatic potentials on the
surface of CXCR4 were calculated using the method as
described above and representatively shown by local energy-
minima conformations in Fig. 4. The surface of ED-CXCR4,
which is in direct contact with the bulky solution at the
outside of the cell membrane, bears a large part of negative
electrostatic potential. The negative electrostatic potential
results mainly from negative charged side chains of residues
Glu2, Asp10, Glu14, Glu15, Asp20, Asp22, Glu26, Glu31,
and Glu32 of the Nter; Asp97 of EL-1; Glu179, Asp181,
Asp182, Asp187, and Asp193 of EL-2; and Glu269, Glu276,
and Glu278 of EL-3. Although the electrostatic potential
distribution was heavily modulated by the tertiary structure
and the exterior shape of ED-CXCR4, the negative elec-
trostatic potential around residues Asp10, Glu14, Glu15,
and Asp20 kept highly conservative throughout all the
conformational ﬂuctuations (Fig. 4). From the viewpoint
FIGURE 3 (A) Time evolution of RMSD from initial structure of MD simulations on Nter and two motifs: motif 1, from residue Ile4 to Tyr12 and motif 2,
from residue Thr13 to Asp22. (B) The RMS ﬂuctuations of the Nter and three loops (EL-1, EL-2, and EL-3) calculated from trajectories at 300 K. All the values
were averaged over individual amino acids. (C) and (D) Stereo view of Ca superposition of conformations from MD snapshots every 50 ps for motif 1 (C) and
motif 2 (D) at Nter.
176 Huang et al.
Biophysical Journal 84(1) 171–184
FIGURE 4 The energy-minima conformations (corresponding to dotted lines in Fig. 2) representing ‘‘opening’’ and ‘‘closing’’ of the binding site at ED-
CXCR4. All conformations are shown in the style of molecular surface colored by its electrostatic potential (the color from red to blue on the color panel, which
shows the electrostatic potential from negative to positive, numerically represents the range from10.5 toþ10.5). Most part of the TMs is not shown for visual
clearance of ED-CXCR4. This ﬁgure was generated by using the GRASP (Nicholls et al., 1991) program.
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of Coulombic interactions, the negative electrostatic poten-
tial around these surface-exposed residues may act as the
important attracting force in the initial step of association
process for SDF-1a—CXCR4 interaction. Meanwhile,
negative electrostatic potential area could also be found
around the conserved residues of Asp262 and Glu288 inside
the TMs domain, and this site is located ;15 A˚ far away
from the negative electrostatic potential ﬁeld of the con-
served cluster at Nter. The features of electrostatic potential
distributionofone energy-minimumconformation at 1.228-ns
trajectory as shown in Fig. 4 indicate that these two negative
electrostatic potential sites would cooperatively interact with
the positive-charged groups of a ligand.
Conformational ‘‘open-close’’ process of ED-CXCR4
Another interesting ﬁnding from the MD simulations is the
opening and closing process of the ‘‘mouth’’ shaped void
situated at the top part of ED-CXCR4 (Fig. 4). During the
ﬁrst several hundred ps, the ‘‘mouth’’ gradually opens up as
the conformation of ED-CXCR4 becomes loosely packed.
This change could be found from the comparison of the
trajectory at 0.845 ns with the initial compact structure. The
‘‘mouth’’ grows up to be the largest ;1.228-ns trajectory as
the Nter and the three loops are at the most relaxed state. The
conformation of ED-CXCR4 opens most extensively and
readily to adopt complementary molecules at that period.
The conserved electrostatic potential area around motif 2 is
fully naked to the exterior solvents. This state of confor-
mation lasts ;100 ps as shown in Fig. 2. Gradually, the
‘‘mouth’’ comes into its closing period as the simulations
go on. It becomes smaller and smaller after a time period of
about 1.0 ns, and almost closes up at 2.44 ns (Fig. 4).
Arg188-Glu277 salt bridge
The charged residues from loops have a crucial function in
the process of the active site formation at ED-CXCR4. Two
representatives of them, Arg188 from EL-2 and Glu277 from
EL-3 (which have close contacts and formed the ‘‘tooth’’
protruding into the ‘‘mouth’’ as obviously shown in Fig. 4),
were selected to analyze the possible electrostatic interac-
tions. Several interatomic distances between the charged
groups of their side chains were computed and their
interacting mode was examined (Fig. 5). Distances from
Cz (Arg188) to Cd (Glu277), Nh1 (Arg188) to Cd (Glu277),
and Nh2 (Arg188) to Cd (Glu277) are;5 A˚ at the ﬁrst 400-ps
simulation. Accordingly, the side chains of Arg188 and
Glu277 interact with each other through direct electrostatic
interactions and hydrogen bonding (Fig. 5 B). As the simu-
lations move on, at ;450 ps, the distances between these
atoms increase to ;8 A˚ (Fig. 5 A). At this time, the side
chain of Glu277 turns away from the side chain of Arg188,
breaking the direct H-bonds formed between these two side
chains, and a network of H-bonds forms, linking the side
chains of Arg188 and Glu277 by several water molecules.
This dynamic state (Fig. 5 C) lasts ;1.10 ns. This indicates
that the salt bridge acts like a ‘‘bolt,’’ so that when it unlocks,
the ED-CXCR4 may open its mouth. As will be seen later,
FIGURE 5 (A) Distance ﬂuctuations for atoms (Cz, Nh1, and Nh2 of Arg188; Cd of Glu277) of the Arg188-Glu277 salt bridge. -n-: Distance from
CzArg188 to CdGlu277; -d-: distance from Nh1Arg188 to CdGlu277; and -m-: distance from Nh2Arg188 to CdGlu277. (B) and (C) Typical interaction
modes (B, Mode I; C, Mode II) of Arg188-Glu277 pair including relative water molecules.
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when SDF-1a binds with CXCR4, this salt bridge adopts its
unlocked state.
Interactions between SDF-1a and CXCR4
Contacts between SDF-1a and CXCR4
CAST (Liang et al., 1998) calculations indicate that there is
a ligand-binding pocket situated near the extracellular side of
TMs domain among TMs III, V, VI, and VII (Site 2). This
binding site is partly covered by ED-CXCR4, especially by
the side chains of Arg188 and Phe189 in EL-2. Molecular
docking identiﬁed the binding orientation and conformation
for residues Lys1 to Leu5 at Nter of SDF-1a. BD simulations
and binding free energy estimations, considering all the
energy-minima conformations (Fig. 4) of ED-CXCR4 as
the possible interactive conformations, demonstrate that
conformation at 1.228 ns in the MD trajectory CXCR4
(Fig. 2) is the most favorable active conformation for SDF-1a
binding. Glu2, Asp10, Glu14, Glu15, Asp20, and Asp22 at
the Nter of CXCR4 are the major components for Site 1.
Arg8, Arg12, Arg41, and Arg47 of SDF-1a may interact
with Site 1 through electrostatic attraction.
Integrating results of molecular docking and BD simu-
lations, we obtained the 3D model of SDF-1a—CXCR4
complex. This model was further optimized by molecular
mechanics. The optimized structure of SDF-1a—CXCR4
complex, and the principal hydrophobic and hydrogen
bonding interactions are represented in Fig. 6 and Table 3.
In general, SDF-1a interacts with CXCR4 via its Nter by
electrostatic and hydrophobic interactions, and hydrogen
bonding. The atomic contacts between side chains of Arg188
and Glu277 were replaced by reasonable interactions be-
tween the ligand and the receptor, indicating the salt bridge
is at its unlocked state in the ligand-receptor complex. The
whole SDF-1a stays above the ED of CXCR4 with its
cationic head penetrating into the binding pocket inside
TMs domain (Site 2). As shown in Fig. 6 and Table 3, two
major electrostatic interaction networks including hydrogen
bonding are formed around the charged residue pairs: one is
formed between Arg8 and Arg12 of SDF-1a and Glu15
and Asp20 of CXCR4, and another is formed between
Lys1 of SDF-1a and Asp262 of CXCR4, which are in cor-
respondence with the binding site in ED-CXCR4 (Site 1) and
the binding site inside TMs domain (Site 2), respectively.
Relative contributions of two binding sites
Using the free energy calculation method encoded in the
AutoDock program (Morris et al., 1998), we calculated the
binding free energies of SDF-1a and its Sites 1 and 2 binding
fragments with CXCR4. The calculated binding free energy
between Lys-Pro-Val-Ser (residues 1–4) at the Nter of
SDF-1a and CXCR4 (DGbind(14)) is 6.59 kcal/mol, and
that between residues 5–13 and CXCR4 (DGbind(513)) is
9.59 kcal/mol. The calculated total binding free energy
DGbind of SDF-1a with CXCR4 is 16.62 kcal/mol, indi-
cating that the interactions between Sites 1 and 2 of CXCR4
with SDF-1a contribute to most of the binding energy, and
Site 1 binding is ;1.5 times stronger than Site 2.
DISCUSSION
We have built a 3D structural model of CXCR4, and per-
formed long-time MD simulations and protein-protein in-
teraction modeling on the SDF-1a—CXCR4 system. The
entire modeling and simulation provide a lot of new insights
into the interaction between SDF-1a and CXCR4. Although
the model of CXCR4 is tentative and requires further
comparison with the x-ray structure coming up in the future,
some basic subjects could be demonstrated according to the
simulation results.
Structure-function relationships
Interpretation of experimental data
The proposed binding model of SDF-1a with CXCR4
(Fig. 6) could be used in explaining the structure-function
relationship of SDF-1a-CXCR4 binding and other related
mutagenesis experiments (Crump et al., 1997; Chabot and
Broder, 2000; Brelot et al., 2000; Gerlach et al., 2001; Hatse
et al., 2001; Gupta et al., 2001; Zhou et al., 2001). The
binding model indicates that the cationic end of Lys1 of
SDF-1a forms two strong H-bonds with the side chain of
Asp262 in Site 2 of CXCR4, and it is apparent that strong
electrostatic interaction should exist between these two
residues (Fig. 6 B). These interactions are well in agreement
with the Asp262Asn (D262N) mutation experiment, which
signiﬁcantly reduces the binding afﬁnity of SDF-1a and the
potency of SDF-1a—induced intracellular calcium signaling
(Hatse et al., 2001). The importance of the conserved residue
Asp262 was also highlighted by the experimental phenom-
ena that the positive-charged molecules, such as AMD3100
and its analogs, could inhibit the bindings of SDF-1a
mediated chemotaxis and [35S]-GTPgS (Gerlach et al.,
2001). Moreover, the 3D model of SDF-1a—CXCR4 is
supported by several other experimental results (Crump et al.,
1997; Brelot et al., 2000): Site 1 at ED-CXCR4 involves in
SDF-1a binding but not signaling; residues Glu14, Glu15,
and Tyr21 at the Nter of CXCR4 have particular importance
in the binding with SDF-1a; and potent antagonism by
mutations of Lys1 and/or Pro2 of SDF-1a (Crump et al.,
1997) surely resulted in decrease of the binding afﬁnity of
SDF-1a with CXCR4. In addition, it was already suggested
that there was a similar binding pocket in the TMs domain
of CXCR4 to that in CCR5 (Moore and Stevenson, 2000;
Chabot and Broder, 2000; Dragic et al., 2000), but it has not
been demonstrated at atomic level. Our simulations have
mapped this binding pocket position and features inside the
TMs (Site 2, Fig. 6, and Table 3), indicating that most of the
residues situated in the binding pocket are considerably
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conserved. The consistency between the 3D model of the
ligand-receptor complex and the experimental results indi-
cates the reasonability of the modeled structure, and the
binding pocket may act as a starting point for structure-based
ligand design.
Most of the site-directed mutagenesis both on Nter of
SDF-1a and two binding sites of CXCR4 have a direct effect
on SDF-1a binding, and then resulting in decrease or even
loss of activation of the receptor (Gerlach et al., 2001; Hatse
et al., 2001; Gupta et al., 2001; Zhou et al., 2001). However,
several mutageneses demonstrated that some residues not
involved in the direct binding contacts between SDF-1a and
CXCR4 may also affect the receptor’s bindings and act-
ivation, such as the mutation studies on Asp97, Asp171, and
Glu288 in the TMs domain; Asp187, Tyr190, Asp193, and
Glu268 in ED-CXCR4; and Glu2, Tyr7, Tyr12, and Tyr21 at
FIGURE 6 (A) A typical ﬁnal complex of SDF-1a—CXCR4. CXCR4 is represented as a molecular surface colored by electrostatic potential (the range of
the color panel is the same as that in Fig. 4), and SDF-1a as a green worm-like structure. (B) Schematic depiction (generated by using LIGPLOT program; see
Wallace et al., 1995) of main interactions between SDF-1a (only the ﬁrst 13 residues were included) and CXCR4.
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the Nter of CXCR4 (Loetscher et al., 1998; Chabot and
Broder, 2000; Brelot et al., 2000; Gerlach et al., 2001; Hatse
et al., 2001; Gupta et al., 2001; Zhou et al., 2001). These
mutations on negative-charged or aromatic residues appear
to modulate the packing and folding of the receptor itself,
or affect the interaction between the TMs and the membrane.
Importance of Arg188-Glu277 salt bridge
As indicated above, electrostatic interactions that originated
from charged amino acids play a major role in determining
how SDF-1a recognizes and interacts with CXCR4. How-
ever, compared with other charged residues, the Arg188-
Glu277 pair has not yet been appreciated by mutagenesis
and binding or functional studies (Gerlach et al., 2001; Hatse
et al., 2001; Gupta et al., 2001; Zhou et al., 2001). As shown
in Fig. 5, intramolecular interactions between Arg188 and
Glu277 directly inﬂuence the ﬁnal complex formation
of SDF-1a—CXCR4. In the inactive conformation of
CXCR4, the Nter and ELs pack tightly, the salt bridge is
locked by H-bonds and electrostatic interactions; as the
MD simulations go on, the salt bridge is unlocked by several
water molecules (Fig. 5 C), and the mouth of ED-CXCR4
opens for SDF-1a binding.
Binding mechanism of SDF-1a with CXCR4
As represented in the dynamic and energetic aspects (Figs.
2–6), the binding mechanism of SDF-1a with CXCR4 could
be clariﬁed at molecular level, and the binding process is
summarized in Fig. 7. Typically, CXCR4 could adopt its
lowest-energy conformation and keep itself in the inactive
state through intramolecular interactions (R state as shown
in Fig. 7 A). The tightly packed ED-CXCR4 becomes
gradually relaxed, and transits between several energy-
minima conformations by molecular thermodynamic motion
and redistribution of its electrostatic potentials on its surface
(Fig. 4). As the chemokine factor SDF-1a approaches the
receptor, a kind of electrostatic signal is transmitted to the
molecular surface of CXCR4. In responding to this speciﬁc
stimulus, CXCR4 changes its conformation and turns into its
Rt state (Fig. 7 A). Initialized by electrostatic attraction,
TABLE 3 Hydrophobic contacts and hydrogen bonds
between side chains of SDF-1a and CXCR4
Hydrophobic contacts
SDF-1a CXCR4
Residue Atom Atom Residue Distance (A˚ )
Lys1 C Cd1 Ile284 3.81
Lys1 Ca Cd1 Ile284 4.57
Lys1 Cg Cd Gln200 4.80
Lys1 Cb Cd Gln200 3.96
Lys1 Cg Ce1 Phe201 4.77
Lys1 Cd Ce1 Phe201 4.66
Lys1 Cg Cz Phe201 4.66
Lys1 Cd Cz Phe201 4.10
Lys1 Ce Cg Asp262 3.39
Pro2 Cd Ce1 Tyr190 3.94
Pro2 Cd Cz Tyr190 4.10
Pro2 Ca Cd1 Ile284 4.56
Val3 Ca Ca Asn278 4.66
Val3 C Cg Asn278 4.30
Val3 C Ca Asn278 4.26
Val3 C Cb Asn278 4.32
Val3 Cb Cg Gln272 4.76
Val3 Ca Cb Gln272 4.76
Val3 Cb Cb Gln272 3.55
Ser4 Cb Cd2 Phe189 4.76
Ser4 Cb Ce2 Phe189 4.62
Ser4 C Cb Glu277 4.88
Ser4 Cb Cg Arg188 3.92
Ser4 Ca Cg Arg188 3.91
Leu5 Cd1 Cb Cys28 4.34
Leu5 Cd2 Cb Cys28 4.31
Leu5 Cd2 Sg Cys28 3.84
Leu5 Cd2 Ce Lys271 3.53
Leu5 Cd1 Ce Lys271 3.78
Leu5 Cd2 Cd Lys271 3.76
Tyr7 Cz Cb Ser23 3.57
Tyr7 Ce2 Cb Ser23 3.36
Tyr7 Cd2 Cb Ser23 3.84
Tyr7 Ce1 Ca Asp22 3.68
Arg8 Cz C Asp20 3.79
Arg8 Cz Cd Glu15 3.75
Arg8 Cd Cb Asn11 3.56
Arg12 Cg Cd1 Ile4 3.67
Arg12 Cz Ca Gly3 3.85
Phe13 Cz Cg1 Ile4 3.56
Phe13 Cz C Gly3 3.85
Phe13 Cd2 Cg Glu15 3.83
Phe13 Cd2 Cb Glu15 3.80
Phe13 Cb C Met16 3.68
Hydrogen bonds
Donor Acceptor
Residue Group Group Residue Distance (A˚ )
Lys1 NzH Od2 Asp262 2.58
Lys1 NzH Od1 Asp262 2.59
Lys1 NH OH Tyr116 2.95
Val3 NH Od1 Asn278 2.83
Tyr7 OH NH Ser23 3.41
Tyr7 OH Od2 Asp22 2.62
Arg8 NH1 Od2 Asp20 2.61
Arg8 NH2 Oe2 Glu15 2.69
Arg8 NH1 Oe1 Glu15 2.60
TABLE 3 (continued )
Hydrogen bonds
Donor Acceptor
Residue Group Group Residue Distance (A˚ )
Arg8 NH1 Oe2 Glu15 3.25
Arg12 NeH Oe1 Glu15 2.66
Arg12 NH2 Od1 Asp20 2.59
Arg12 NH2 Oe1 Glu15 3.04
Arg12 NH2 O Thr13 2.69
Arg12 NH1 O Asn11 2.65
Arg12 NH1 Od2 Asp10 2.64
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SDF-1a binds with CXCR4 at Site 1. As a result of steric
complementary and further electrostatic attraction, binding at
Site 1 promotes the disruption of the Arg188-Glu277 salt
bridge. Site 2 inside the TMs domain is totally exposed and
therefore could bind with the Nter of SDF-1a. This two-site
binding action drives CXCR4 receptor to its bioactive
conformation (R* state in Fig. 7 A). During the whole
binding process, electrostatic stimulus is transferred to the
intracellular end through the motion of TMs domain. Some
positively charged residues near the intracellular end of TMs
domain act as the ﬁnal processor for the stimulant, and the
active receptor is ready to couple with G-proteins; thus,
the active CXCR4 transfers signals from outside to inside of
the cell. Similar to the transmembrane signaling of aspartate
receptor (Ottemann et al., 1999), the harmonious conforma-
tional changes during SDF-1a—CXCR4 binding just like
a piston movement. This is in agreement with the generally
recognized conclusion that signiﬁcant conformational rear-
rangements must be accompanied in the process of agonist-
induced activation and signal transduction of GPCRs
(Palczewski et al., 2000; Teller et al., 2001; Gether and
Kobilka, 1998; Shapiro et al., 2000; Grobner et al., 2000).
Using TM truncation and reconstruction approach, it has
been tested (Ling et al., 1999) that deletion of TMs I and II
has no obvious impairment on CCR5 and CXCR4 for their
function as normal chemokine receptors in mediating
chemokine-stimulated chemotaxis, Ca2þ inﬂux, and activa-
tion of pertussis toxin-sensitive G-proteins. These experi-
mental results combined with other studies (Chabot and
Broder, 2000; Brelot et al., 2000; Ling et al., 1999; Gerlach
et al., 2001; Hatse et al., 2001; Gupta et al., 2001; Zhou
et al., 2001) directly emphasized the relative importance
of different TMs in the process of signal transduction.
Comparing the conformation R state of CXCR4 with its R*
state, the radius of gyration (RG) changes from 2.217 nm to
2.246 nm, and the RMSD of the Ca atoms of the seven TMs
has the value of 0.95. These geometrical parameters indicate
that in binding with SDF-1a, conformation of ED-CXCR4
changes dramatically (Figs. 4 and 5), and the conformations
of the TMs also change in some degree and become more
relaxed. Structural alignment indicates that small changes
occur for TMs I, II, III, IV, V, and VII; however, great
motion happens for TM VI due to the pressure of ED-
CXCR4 (Fig. 7 B). This indicates that TM VI plays an
important role in the process of SDF-1a binding, confor-
mational change, electrostatic stimulus transferring, and G-
protein coupling, which is in agreement with the weak
interaction of TM VI with other TMs (Fig. 1). Therefore we
suggest much attention should be paid to TM VI in the
functional studies of CXCR4.
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